KK
ABBV icon

KLP Kapitalforvaltning’s AbbVie ABBV Stock Holding History

KLP Kapitalforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174M Buy
798,372
+24,300
+3% +$5.39M 0.68% 18
2025
Q4 		$177M Buy
774,072
+29,600
+4% +$6.74M 0.68% 18
2025
Q3 		$172M Buy
744,472
+8,600
+1% +$1.75M 0.68% 19
2025
Q2 		$137M Buy
735,872
+19,100
+3% +$3.55M 0.59% 22
2025
Q1 		$150M Buy
716,772
+13,600
+2% +$2.64M 0.74% 20
2024
Q4 		$125M Buy
+703,172
New +$129M 0.59% 23

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KLP Kapitalforvaltning's ABBV Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its AbbVie (ABBV) stake by 3.1% in Q1 2026, buying an estimated $5.39M and bringing the position to 798,372 shares worth $174M. The position accounts for 0.68% of the portfolio, ranked #18.

KLP Kapitalforvaltning first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $177M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • KLP Kapitalforvaltning held 798,372 shares of AbbVie worth $174M as of Q1 2026.
  • KLP Kapitalforvaltning bought 24,300 AbbVie shares in Q1 2026, an estimated $5.39M.
  • AbbVie made up 0.68% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #18 holding.
  • KLP Kapitalforvaltning first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's AbbVie position peaked at $177M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.